Effect of Nurse-Directed Therapeutic Positioning in Children With Pneumonia
Effectiveness of Nurse- Directed Therapeutic Positioning on Vital Signs, Oxygen Saturation, and Respiratory Distress Severity Among Children With Pneumonia: A Comparative Study
Pneumonia is a common respiratory infection in children that may cause respiratory distress and impaired oxygenation. This quasi-experimental study aims to evaluate the effectiveness of nurse-directed therapeutic positioning on vital signs, oxygen saturation, and respiratory distress severity among children aged 3-5 years diagnosed with pneumonia. The study will compare two therapeutic positioning interventions, side-lying position and semi-Fowler's position, with a control group receiving routine nursing care. The outcomes will be assessed to determine the effects of these positioning interventions on the respiratory status of children with pneumonia.
Обзор исследования
Статус
Условия
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Nidaa H Mardan
- Номер телефона: +9647807779284
- Электронная почта: nedaa.hazem2504m@conursing.uobaghdad.edu.iq
Учебное резервное копирование контактов
- Имя: Adraa H Shawq, Phd
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Children aged 3-5 years.
- Children diagnosed with pneumonia.
- Children admitted to the selected pediatric hospitals.
- Children whose parents/guardians provide informed consent.
Exclusion Criteria:
- Children with chronic respiratory diseases.
- Children with congenital heart disease.
- Children with neuromuscular disorders.
- Children requiring mechanical ventilation
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Нерандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Side - Lying position Group
Children aged 3-5 years diagnosed with pneumonia will receive nurse-directed therapeutic positioning in the side-lying position. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol. |
Nurse-directed therapeutic positioning will be implemented for children aged 3-5 years diagnosed with pneumonia. Children assigned to this group will be placed in the side-lying position under nursing supervision, with attention to comfort, safety, and clinical tolerance. The selected side, duration of each positioning session, frequency of application, and total intervention period will be specified in the study protocol. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study's measurement schedule to evaluate changes following the intervention. |
|
Экспериментальный: Semi - Fowler's Position Group
Children aged 3-5 years diagnosed with pneumonia will receive nurse-directed therapeutic positioning in the semi-Fowler's position. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol. |
Nurse-directed therapeutic positioning will be implemented for children aged 3-5 years diagnosed with pneumonia. Children assigned to this group will be positioned in the semi-Fowler's position, with the head and upper body elevated according to the study protocol. Nursing supervision will be provided to maintain the child's comfort and safety and to monitor clinical tolerance. The elevation angle, duration of each positioning session, frequency of application, and total intervention period will be specified in the study protocol. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study's measurement schedule to evaluate changes following the intervention. |
|
Без вмешательства: Control Group
Children aged 3-5 years diagnosed with pneumonia will receive routine nursing care according to the hospital's standard practice. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change in Respiratory Rate
Временное ограничение: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Respiratory rate will be measured in breaths per minute and compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
|
Change in Respiratory Distress Severity
Временное ограничение: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Respiratory distress severity will be assessed using the Clinical Respiratory Score (CRS), which consists of six parameters: respiratory rate, auscultation, use of accessory muscles, mental status, room air oxygen saturation, and skin color. Each parameter is scored from 0 to 2, yielding a total score ranging from 0 to 12. Higher scores indicate greater respiratory distress. Change in respiratory distress severity will be compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
Временное ограничение: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Peripheral oxygen saturation will be measured using a pulse oximeter and compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
|
Change in Heart Rate
Временное ограничение: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Heart rate will be measured in beats per minute and compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Adraa H Shawq, Phd, University of Baghdad, College of Nursing
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- NUR-TP-PNEU
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Individual participant data will not be shared with other researchers. Data confidentiality will be maintained, and study findings will be reported in aggregate form without identifying individual participants.
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .